Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Oct 31, 2023 | (FY)Oct 31, 2022 | (FY)Oct 31, 2021 | |
---|---|---|---|
Operating cash flow (Indirect Method) | |||
Cash from operating activities | 174.32%107.35M | 156.00%39.13M | -69.88M |
Net profit before non-cash adjustment | 317.09%97.89M | 130.07%23.47M | ---78.06M |
Total adjustment of non-cash items | 1,263.74%19.48M | -111.54%-1.67M | --14.51M |
-Depreciation and amortization | 59.22%3.42M | -7.85%2.15M | --2.33M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | --1.49M |
-Disposal profit | ---- | ---- | --3.12M |
-Other non-cash items | 520.23%16.06M | -150.48%-3.82M | --7.57M |
Changes in working capital | -157.86%-10.03M | 373.75%17.33M | ---6.33M |
-Change in receivables | -167.00%-40.87M | -1.38%-15.31M | ---15.1M |
-Change in inventory | 280.00%19K | 120.00%5K | ---25K |
-Change in payables | -46.51%15.98M | 315.32%29.87M | --7.19M |
-Provision for loans, leases and other losses | 872.61%14.84M | -4.63%1.53M | --1.6M |
-Changes in other current assets | --0 | --1.24M | --0 |
Dividends paid (cash flow from operating activities) | |||
Dividends received (cash flow from operating activities) | |||
Interest paid (cash flow from operating activities) | -3.55%-1.08M | 27.13%-1.04M | -1.43M |
Interest received (cash flow from operating activities) | 0.00%2K | -33.33%2K | 3K |
Tax refund paid | -836.41%-1.44M | 104.72%195K | -4.13M |
Other operating cash inflow (outflow) | 0 | 1K | 0 |
Operating cash flow | 173.81%104.83M | 150.75%38.29M | ---75.44M |
Investing cash flow | |||
Net PPE purchase and sale | 40.98%-625K | 58.55%-1.06M | ---2.56M |
Net intangibles purchase and sale | ---10.06M | --0 | ---2.75M |
Net investment product transactions | --1M | --0 | ---- |
Net changes in other investments | 106.15%325K | -315.57%-5.29M | ---1.27M |
Investing cash flow | -47.58%-9.36M | 3.53%-6.35M | ---6.58M |
Financing cash flow | |||
Net issuance payments of debt | 60.06%-12.07M | 2.64%-30.23M | ---31.05M |
Net common stock issuance | --318.06M | --0 | --39.92M |
Issuance fees | ---2.88M | --0 | ---- |
Net other fund-raising expenses | ---- | ---166K | ---- |
Financing cash flow | 1,097.30%303.11M | -442.65%-30.39M | --8.87M |
Net cash flow | |||
Beginning cash position | 0.81%191.98M | -27.75%190.44M | --263.58M |
Current changes in cash | 25,631.18%398.58M | 102.12%1.55M | ---73.15M |
Effect of exchange rate changes | ---- | ---- | --0 |
End cash Position | 207.61%590.56M | 0.81%191.98M | --190.44M |
Free cash flow | 152.88%94.14M | 146.11%37.23M | ---80.75M |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |